Tech Company Financing Transactions
Exogenesis Funding Round
On 12/31/2010, Exogenesis secured $3.2 million in funding from Inflection Point Ventures.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$3,190,000
Round
Undisclosed
Investors
Inflection Point Ventures (Michael O'Malley)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
20 Fortune Dr.
Billerica, MA 01821
USA
Billerica, MA 01821
USA
Phone
Website
Email Address
Overview
Exogenesis is seeking partners in collaborative research and commercialization of its proprietary nanoscale surface modification technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dmitry Shashkov
VP - Engineering
James Bachand
VP - Engineering
Allen Kirkpatrick
VP - Product Management
Michael Walsh
Browse more venture capital transactions:
Prev: 12/31/2010: Mercent venture capital transaction
Next: 12/31/2010: Adku venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs